Sen. McCaskill Report Shows Medicare Could Save Billions With Negotiation on Prescription Drug Prices
"When we don't let Medicare negotiate for better prices, it puts the profits of big pharma ahead of the interests of
The report compared Medicare Part D spending on the 20 most commonly prescribed brand-name drugs in the program to corresponding prices negotiated by the
The report's key findings include:
* Even when applying the average rebate amount--17.5%--for Medicare Part D brand-name drugs published by the
* Negotiated federal drug prices rose at significantly lower rates than list prices for the top 20 most commonly prescribed brand-name drugs in Medicare Part D. After adjusting for inflation, the average list price for these drugs in the Part D program rose from
* The federal government spent over
READ THE REPORT: Manufactured Crisis: How Better Negotiation Could Save Billions for Medicare and America's Seniors (https://www.hsgac.senate.gov/download/manufactured-crisis-how-better-negotiation-could-save-billions-for-medicare-and-americas-seniors)
McCaskill has made tackling rising healthcare and prescription drug costs a top priority in the
During McCaskill's time as the top Democrat on the
Earlier this year in February, healthcare and emergency room costs in
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News